Merrion Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,000
| Closed | -$291K | – | 105 |
|
2024
Q3 | $291K | Hold |
2,000
| – | – | 0.19% | 86 |
|
2024
Q2 | $275K | Hold |
2,000
| – | – | 0.19% | 83 |
|
2024
Q1 | $274K | Sell |
2,000
-650
| -25% | -$89.2K | 0.2% | 87 |
|
2023
Q4 | $360K | Sell |
2,650
-2,000
| -43% | -$272K | 0.28% | 66 |
|
2023
Q3 | $569K | Hold |
4,650
| – | – | 0.49% | 42 |
|
2023
Q2 | $590K | Sell |
4,650
-50
| -1% | -$6.35K | 0.5% | 41 |
|
2023
Q1 | $607K | Sell |
4,700
-100
| -2% | -$12.9K | 0.58% | 34 |
|
2022
Q4 | $630K | Hold |
4,800
| – | – | 0.59% | 36 |
|
2022
Q3 | $561K | Hold |
4,800
| – | – | 0.55% | 41 |
|
2022
Q2 | $565K | Sell |
4,800
-1,000
| -17% | -$118K | 0.55% | 42 |
|
2022
Q1 | $755K | Hold |
5,800
| – | – | 0.55% | 36 |
|
2021
Q4 | $885K | Hold |
5,800
| – | – | 0.65% | 32 |
|
2021
Q3 | $937K | Hold |
5,800
| – | – | 0.71% | 29 |
|
2021
Q2 | $949K | Hold |
5,800
| – | – | 0.72% | 32 |
|
2021
Q1 | $873K | Hold |
5,800
| – | – | 0.73% | 31 |
|
2020
Q4 | $879K | Buy |
+5,800
| New | +$879K | 0.74% | 31 |
|